Initial effectiveness of radiofrequency ablation of the autonomously functioning thyroid nodules

Dr Le Thi My1, professor Pham Minh Thong1, Dr Vu Dang Luu
1 Radiology Center - Bach Mai Hospital

Main Article Content

Abstract

Objective: Some patients with autonomously functioning thyroid nodules (AFTN) are not suitable for surgery or radioiodine therapy. Therefore, minimally invasive alternative treatments, such as ethanol ablation or radiofrequency ablation (RFA), are necessary.
Methods: This study included seven patients (7 toxic and 10 pretoxic patients; male to female ratio = 1:7.5; mean age, 46.47 ± 13 (range, 22–66) years) who were not eligible for surgery or radioiodine therapy. All of the patients showed hot nodule with suppression of normal thyroid gland in 99mTc pertechnetate scintigraphy. RFA was performed using a 18 gauge internally cooled electrode. Nodule volume, thyroid function, scintigraphy, symptom score (visual analogue scale, 0–10cm),
cosmetic grading score (4 point scale), and complications were evaluated before treatment and at 1, 3, 6 months follow-up.
Results: Mean volume of the index nodule was 13.07 ± 8.44 (range, 2.2–35.5) mL. After RFA, The volume reduction at 1month, 3
months, 6 months follow up was 42.77 % , 63. % và 78.3 % . Initial mean T3, FT4, and TSH were 2.59 ± 1.19nmol/L, 16.3 ± 5.78pmol/L, and 0.101 ± 0.178 mU/mL, respectively. A significant improvement of mean T3, FT4, and TSH were observed after 1month (T3: 2.18 ± 0.753 nmol/L, p = 0.001; FT4: 14.78 ± 2.86 pmol/L, p = 0.026; TSH: 1.464 ± 0.844 mU/mL, p = 0.001), after 6 months (T3: 2.07 ± 0.614 nmol/L, p = 0.012; FT4: 15.12 ± 2.0 pmol/L, p = 0.001; TSH: 1.269 ± 0.398 mU/mL, p < 0.001). After ablation, 16 patients became a cold or normal scan and one patient uptake similar normal thyroid tissue. After 6 months, the
mean symptom was reduced from 3.47 ± 1.9 to 0.12± 3.32 (p = 0.001) and cosmetic grading score was reduced from từ 3.59 ± 1.1 tới 1.41± 0.712 (p = 0.712) (p <0.001). No major complications were encountered.
Conclusions: RFA was effective and safe for treating autonomously functioning benign thyroid nodules and it might be recommended for treating hot benign thyroid nodules as the first-line treatment

Article Details

References

1. Gharib, H., et al., american association of clinical endocrinologists, american college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules – 2016 update. Endocrine practice, 2016. 22(supplement 1): p. 1-60.
2. Baek, j.h., a guidebook on radiofrequency ablation for thyroid and neck tumors. 2017.
3. Kim, j.-h., et al., 2017 thyroid radiofrequency ablation guideline: korean society of thyroid radiology. Korean journal of radiology, 2018. 19(4): p. 632-655.
4. Sung, j.y., et al., radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid, 2015. 25(1): p. 112-7.
5. Baek, j.h., et al., radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World j surg, 2009. 33(9): p. 1971-7.
6. Belfiore, a., et al., solitary autonomously functioning thyroid nodules and iodine deficiency*. The journal of clinical endocrinology & metabolism, 1983. 56(2): p. 283-287.
7. Park, h.s., et al., thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean j radiol, 2017. 18(4): p. 615-623.
8. Na, d.g., et al., radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean j radiol, 2012. 13(2): p. 117-25.